For more information or confidential assistance
800-306-3180
se habla español

Lawsuit Questions Xarelto Safety

  Another lawsuit has been transferred to the Xarelto multidistrict litigation (MDL) No. 2592, which is pending in the U.S. District Court for the Eastern District of Louisiana under Judge Fallon. The plaintiff, Cheryl Butler, claims the defendants, Janssen Pharmaceuticals, Bayer Healthcare Pharmaceuticals, et al. fraudulently misrepresented the safety of the... Read more »

Intracranial Hemorrhage Subject of Xarelto Lawsuit

For patients suffering from the condition known as atrial fibrillation – or “A-fib” – an anti-coagulant drug is often used to help prevent the formation of deadly blood clots. For generations, doctors prescribed the drug known as warfarin to A-fib patients, until the newer blood thinning drug Xarelto was introduced... Read more »

Bayer Faces Xarelto Class Action Lawsuit in Canada

In addition to a growing number of cases in the United States, Bayer now faces a Xarelto class action lawsuit in Canada. Plaintiff Betty Samson filed the complaint in Calgary and another is likely to follow in Ontario, where an elderly woman bled to death while taking the drug. The complaint includes... Read more »

Research Misconduct Involving Xarelto Goes Unreported

JAMA Internal Medicine recently published a study by Charles Seife that highlights a profound flaw in how consumers obtain information about clinical drug trials. According to the New York University professor, only 4 percent of questionable practices or violations discovered by health regulators during pharmaceutical trials ever reaches the public.... Read more »

Report Indicates Xarelto Clinical Trials Likely Riddled with Misconduct, Fraud

The U.S. Food and Drug Administration (FDA) is charged with overseeing the safety and efficacy of new prescription medications for eventual approval. This process involves reviewing sites where clinical trials on medications are performed. Occasionally, health officials discover evidence that drug companies and their researchers have deviated from good clinical practice... Read more »

Xarelto Lawsuits Gain Plaintiffs’ Steering Committee

To date, about 100 Xarelto lawsuits filed in federal court systems have been centralized into a multidistrict litigation (MDL), which is proceeding in the U.S. District Court for the Eastern District of Louisiana. Judge Eldon E. Fallon is presiding over the MDL, which was established in December 2014 by the... Read more »

Xarelto Bleed Victims Join Mass Tort in Philadelphia

Administrative Judge Kevin Dougherty of the Philadelphia Court of Common Pleas recently issued an order that has created a mass tort docket for Xarelto lawsuits filed against Janssen Pharmaceuticals and Bayer Healthcare Pharmaceuticals. The January 21, 2015 order affects at least 75 cases that share common allegations regarding the medication,... Read more »

New Xarelto Bleeding Lawsuit Filed in California

Fraudulent concealment, negligence and fraud are just some of the causes of action leveled against Xarelto manufacturers by a California plaintiff who suffered personal injuries after ingesting the drug. The product liability lawsuit is just one of dozens which claim the anticoagulant is defective and inherently dangerous due to its... Read more »

Xarelto Lawsuits Consolidated Into Multi-District Litigation

Over the past several years, the highly-anticipated next-generation blood thinner Xarelto has transformed from an exciting new addition to the American drug market to a potentially dangerous, even life-threatening treatment. Xarelto, which was designed and manufactured by Bayer and Johnson & Johnson subsidiary Janssen, has been named in 21 federal... Read more »

Study Shows Xarelto Bleeding Risks Equivalent to Warfarin

New research published in the Canadian Journal of Cardiology suggests that Pradaxa and Xarelto bleeding risks may be no different than those of Warfarin (Coumadin). The study – conducted at Southlake Regional Health Centre in Ontario– examined 901 patients who took Warfarin and newer anticoagulants Pradaxa and Xarelto. After looking... Read more »